Log in to save to my catalogue

Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosi...

Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2711308051

Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis

About this item

Full title

Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis

Publisher

Singapore: Springer Nature Singapore

Journal title

Journal of gastroenterology, 2022-11, Vol.57 (11), p.902-912

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Scope and Contents

Contents

Background
It remains unclear whether ursodeoxycholic acid (UDCA) treatment improves long-term outcomes in patients with primary sclerosing cholangitis (PSC). In this study, we investigated whether UDCA treatment is associated with improved liver transplantation (LT)-free survival in a cohort of Japanese patients with PSC.Journal instruction req...

Alternative Titles

Full title

Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2711308051

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2711308051

Other Identifiers

ISSN

0944-1174

E-ISSN

1435-5922

DOI

10.1007/s00535-022-01914-3

How to access this item